Although miR-130b mimic nor inhibitor had no significant effect on TIMP2 expression at the mRNA level in NSCLC cells, miR-130b might affect TIMP-2 expression at the transcriptional level via targeting Sp1 transcriptional factor in other types of cancer such as breast cancer. Here, TIMP2 is linked to non-small cell lung carcinoma.